48
Views
4
CrossRef citations to date
0
Altmetric
Short Report

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype

, , , , &
Pages 3879-3884 | Published online: 29 Nov 2018

References

  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • KannerREAnthonisenNRConnettJELung Health Study Research GroupLower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
  • Global Initiative for Chronic Obstructive Pulmonary DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdfAccessed August 21, 2018
  • ConnorsAFDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)Am J Respir Crit Care Med19961544 Pt 19599678887592
  • HoogendoornMHoogenveenRTRutten-van MölkenMPVestboJFeenstraTLCase fatality of COPD exacerbations: a meta-analysis and statistical modelling approachEur Respir J201137350851520595157
  • SuissaSDell’anielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
  • BeehKMGlaabTStowasserSCharacterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialRespir Res20131411624168767
  • HanMKQuibreraPMCarrettaEEFrequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortLancet Respir Med20175861962628668356
  • SukkarMBWoodLGToozeMSoluble RAGE is deficient in neutrophilic asthma and COPDEur Respir J201239372172921920897
  • MccanceDRDyerDGDunnJAMaillard reaction products and their relation to complications in insulin-dependent diabetes mellitusJ Clin Invest1993916247024788514859
  • MukhopadhyaySMukherjeeTKBridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspectiveBiochim Biophys Acta20051745214515515890418
  • YonchukJGSilvermanEKBowlerRPCirculating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lungAm J Respir Crit Care Med2015192778579226132989
  • ChenMWangTShenYKnockout of RAGE ameliorates mainstream cigarette smoke-induced airway inflammation in miceInt Immunopharmacol20175023023528704797
  • LeeHParkJRKimWJBlockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signalingFaseb J20173152076208928148566
  • ReynoldsPRKastelerSDSchmittREHoidalJRReceptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammationAm J Respir Cell Mol Biol201145241141821131443
  • RobinsonABJohnsonKDBennionBGReynoldsPRRAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammationAm J Physiol Lung Cell Mol Physiol201230211L1192L119922505673
  • LiYYangCMaGAssociation of polymorphisms of the receptor for advanced glycation end products gene with COPD in the Chinese populationDNA Cell Biol201433425125824520905
  • CastaldiPJChoMHSan José EstéparRGenome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patternsAm J Respir Crit Care Med2014190439940925006744
  • ManichaikulAHoffmanEASmolonskaJGenome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource StudyAm J Respir Crit Care Med2014189440841824383474
  • ChoMHCastaldiPJHershCPA Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging PhenotypesAm J Respir Crit Care Med2015192555956926030696
  • YoungRPHayBAHopkinsRJDoes RAGE protect smokers from COPD?Eur Respir J201138374374421885423
  • ChenLLiuLWangTShenYCWenFQReceptor for advanced glycation end products: a new theraputic target for chronic obstructive pulmonary disease?Arch Med Res2013441757623287523
  • ChoiBCSlopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic testAm J Epidemiol199814811112711329850136
  • Core Team RR: A Language and Environment for Statistical ComputingR Foundation for Statistical ComputingVienna, Austria2016
  • GolpeRSuárez-ValorMMartín-RoblesIMortality in COPD patients according to clinical phenotypesInt J Chron Obstruct Pulmon Dis2018131433143929750029
  • Le RouzicORocheNCortotABDefining the “Frequent Exacerbator” Phenotype in COPD: A Hypothesis-Free ApproachChest201815351106111529054347
  • GuptaPPGovidagoudarMBYadavRAgarwalDClinical and pulmonary functions profiling of patients with chronic obstructive pulmonary disease experiencing frequent acute exacerbationsLung India2018351212629319029
  • OhJYSinDDLung inflammation in COPD: why does it matter?F1000 Med Rep201242323236338
  • BlumenthalJAEmeryCFSmithPJThe effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II studyPsychosom Med201476858159225251888